Evidence map›Paper›PMID 22218879›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2012

Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.

Victor L Villemagne, William E Klunk, Chester A Mathis, Christopher C Rowe, David J Brooks, Bradley T Hyman, Milos D Ikonomovic, Kenji Ishii, Clifford R Jack, William J Jagust and 14 more

Abstract readEditorialComment
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. A brief history of Aβ imaging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  3. Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Uses of Human MR and PET Imaging in Research of Neurodegenerative Brain Diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  7. Article
  8. Article
  9. Proven validity and management impact of amyloid imaging in Alzheimer's disease-repetita juvant.European journal of nuclear medicine and molecular imaging · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Untangling tau imaging.Alzheimer's & dementia (Amsterdam, Netherlands) · 2016
    Review
  16. Imaging frontotemporal lobar degeneration.Current neurology and neuroscience reports · 2014
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Victor L Villemagne
William E Klunk
Chester A Mathis
Christopher C Rowe
David J Brooks
Bradley T Hyman
Milos D Ikonomovic
Kenji Ishii
Clifford R Jack
William J Jagust
Keith A Johnson
Robert A Koeppe
Val J Lowe
Colin L Masters
Thomas J Montine
John C Morris
Agneta Nordberg
Ronald C Petersen
Eric M Reiman
Dennis J Selkoe
Reisa A Sperling
Koen Van Laere
Michael W Weiner
Alexander Drzezga

Funding

Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI GONZALEZ HERNANDEZ, GRACIELA · 2001 to 2020
$32.5M
AGING IN THE BRAIN--ROLE OF THE FIBROUS PROTEINSR01AG006173 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SELKOE, DENNIS J · 1985 to 2016
$2.5M
Medical Research Council G1100810Medical Research Council MC_U120036861NIA NIH HHS P30 AG019610NIA NIH HHS R01 AG006173
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesHumansPositron-Emission TomographyRadioisotopesAmyloid beta-PeptidesRadioisotopes

Identifiers

PMID22218879
PMCPMC3261395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.